Entdecken Sie eBooks
Kategorien
Entdecken Sie Hörbücher
Kategorien
Entdecken Sie Zeitschriften
Kategorien
Entdecken Sie Dokumente
Kategorien
Washington, D.C.
In the Matter of
inviting interested parties and members of the public to file comments on the above-
observations in response to the statements from Apple, Fair Standards Alliance, and the
App Association.
I currently serve as vice president for research and technology transfer at Colorado
to previously serve our Nation as Under Secretary of Commerce for Standards and
Technology and 16th director of the National Institute of Standards and Technology
(NIST). I have over 20 years of experience in the licensing and technology transfer field.
I began my career in research and development and business leadership at the Lubrizol
administration studies at Harvard Business School. I was named 2020 laboratory director
of the year by the U.S. Federal Laboratory Consortium and the Association of University
Technology Managers (AUTM) recognized me with its 2021 Bayh-Dole Award for
contributions to U.S. innovation and technology transfer. The Foundation for the
Malcolm Baldrige National Quality Award has announced that I am recipient of the 2022
research and development (“R&D”) that lead to technology standardization are ultimately
2
intended to provide such innovators opportunities for product sales, as well as to achieve
fair and equitable financial returns by licensing to other parties these intellectual
that all remedies should be available to Standard Essential Patent (“SEP”) holders to be
able to uphold their rights as they seek to achieve appropriate returns on their
investments. In certain instances, issuance of an exclusion order for SEPs for which a
voluntary commitment has been provided to license on Fair, Reasonable, and Non-
Discriminatory (“F/RAND”) terms would be consistent with the public interest. Such
effectively issued exclusion orders encourage competition in the United States, help bring
upheld even in the event of F/RAND commitments. In sum, the F/RAND commitment
available as a remedy.
United States and supports commerce and international trade on fair and reasonable
terms. It is in the public interest for an SEP holder to have access to all remedies
3
available at law in the event of infringement of their intellectual property rights, and
Protecting the fruits of their labors as well as their U.S. Constitutional rights in
intellectual property through the trustworthy applications of law are critically important
to encourage new research and product investment. These principles provide the
foundation for ongoing innovation, and enable future valuable products and services that
create jobs and grow the economy. However, when an innovator loses revenue as the
result of being compelled into a SEP license, that financial loss means a further
injunction allows for investment revenue to be recovered, and for innovation and
competition to further increase when parties enter a license agreement in good faith.
Other policy reasons to allow for injunctions within the SEP context are found in
2019. Therein the Department of Justice, United States Patent and Trademark Office and
NIST maintain that “A balanced, fact-based analysis, taking into account all available
remedies, will facilitate, and help to preserve competition and incentives for innovation
activity.”1
1
“Policy Statement on Remedies for Standard-Essential Patents Subject to Voluntary F/RAND
Commitments” (2019 Policy Statement) https://www.justice.gov/atr/page/file/1228016/download
- at 7.
4
In addition, SEP holders need all available remedies to help bring products to
market and to be able to recoup their R&D and other investments into cutting-edge
technology. Creating intellectual property and protecting intellectual property rights are
both critically important elements to allow innovators to achieve rewards for the risks
they take, and to further increase market competition in the United States.
Not only does the federal government agree that all remedies should be available
to SEP holders, but the Supreme Court and Federal Circuit both have held that F/RAND
that such commitments are not dispositive of the opportunity to seek and to deploy
Essential Patent holder. However, SEP holder should not be compelled to grant a license
and forego potential remedies simply because a potential licensee does not want to pay a
fair market price for the patented technology. The F/RAND commitments themselves do
not state nor imply that an SEP holder foregoes any remedy at all. The 2019 Policy
Statement further notes:“[t]he rejection of a special set of legal rules that limit remedies
consistent with the holdings of the U.S. Courts to date. For example, in the eBay Case,
the U.S. Supreme Court made clear that traditional principles of equity apply in
2
Apple Inc. v. Motorola, Inc., 757 F.3d 1286 (Fed. Cir. 2014). Id. 1331–32 (Reyna, J. for the
Court) (“To the extent that the district court applied a per se rule that injunctions are unavailable
for SEPs, it erred.”); Id. at 1333 (Rader, J. dissenting in part) (There is “no per se rule either
favoring or proscribing injunctions for patents in any setting, let alone the heightened complexity
of standardized technology.”); Id. at 1342 (Prost, J. concurring in part) (“[T]here is no need to
create a categorical rule that a patentee can never obtain an injunction on a FRAND-committed
patent.”).
5
determining whether an injunction should issue in any patent case in federal court.”3
Therefore, it would be wholly inappropriate to rule out any and all injunctive relief
opportunities available without considering all of the facts relevant to the intellectual
F/RAND considerations are directly relevant to the public interest factors that the
ITC considers when granting an exclusion order, including the competitive conditions in
the United States economy and the potential impact on United States consumers.4
Although I do not take a position on the specifics of the case in question, based on
decades of IP transaction history in the U.S. and internationally it is clear that injunctions
and other remedies must be available to IP owners. Such remedies are both appropriate
and necessary to enable fair transactions, to increase market competition and enhance
consumer choice in the context of SEPs and F/RAND negotiations. Given the global
rewarded for the investments and risks they take to bring new products to market to better
Walter G. Copan
February 4, 2022
3
2019 Policy Statement at 6, and See eBay Inc., 547 U.S. at 391–93.
4
See 19 § CFR 210.50.
6
CERTIFICATE OF SERVICE